Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The real question now: Are we going to see Novo regaining market share from Eli Lilly
Retatrutide is the only late-stage compound that provides significant glucagon receptor activation alongside GLP-1 and GIP agonism
Clinical evidence supports GLP-1 receptor activation as a mechanism for appetite regulation and metabolic improvement
It is noteworthy that the study only included data from the US and comprised a smaller number of patients receiving semaglutide QW, likely as a result of recent product launch, compared with those receiving the comparators
US$ 27.69
US$ 29.68
US$ 22.20
US$ 26.32
US$ 23.49
&srotate=0)
